Please login to the form below

Not currently logged in
Email:
Password:

Medmeme bolsters its sales team

Franco Barbalinardo joins as senior vice president, sales and business

Franco Barbalinardo Medical affairs solutions group Medmeme has appointed Franco Barbalinardo as its senior vice president for sales and business, following more than 20 years’ healthcare experience.

Barbalinardo’s background includes roles on both the manufacturer and vendor side and his expertise spans across the commercial, analytics, medical affiars, R&D and life science functions.

He joins the group from Carson Analytics, where he was senior vice president of sales and marketing, responsible for re-branding an re-launching the company.

Mahesh Naithani, founder of Medmeme, said: “Franco is ideally placed to drive sales for Medmeme’s unique offering which can yield transformative and market-differentiating benefits for pharma and other healthcare organisations.”

Barbalinardo has also held roles for Aileron Solutions – which was acquired by IMS Health in 2014 -, Within3, and Pfizer.

Naithani added: “We are very pleased to welcome Franco to our team and we look forward to working with him.”

27th September 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics